2Sulkes A,Smyth J,Sessa C,et al.Docetaxel (Taxotere) in advanced gastric cancer:results of a phase Ⅱ clinical trial.EORTC Early Clinical Trials Group[J].Br J Cancer,1994,70(2):380-383.
3Comis TL,Carter SR.A review of chemotherapy in gastric cancer[J].Cancer,1974,34(5):1576-1586.
4金懋林.中国临床肿瘤学教育专辑[M].北京:中国医药科技出版社出版,2000.143-154.
5Hainsworth JD,Burris HA,Erland JB,et al.Phase I study of docetaxol administered by weekly infusion inpatients with advanced refractory cancer[J].J Clic Oncol,1998,16(6):2164-2168.
6Lee SH,Kang WK,Park J,et al.Combination chemotherapy with epirubicin,docetaxel and cisplatin (EDP) in metastatic or recurrent,unresectable gastric cancer[J].Br J Cancer.2004,91(1):18-22.
7Ajani JA.Docetaxel for gastric and esophageal carcinomas[J].Oncology.2002,16(Suppl 6):89-96.
8Ajani JA,Van Cutsem E,Moisey NV,et al.Docetaxel (D),cisplatin,5 fluorouracil compare to cisplatin (C) 5 fluorouracil (F) for chemotherapy paive patients iwth metastatic or locally recurrent,unresectable gastric carcinoma (MGC):Interin results of a randomized phase Ⅲ trial (V325)[J].Proc Am Soc Clin Oncol,2003,22:249 (abstra 999).
